MDT

81.74

-1.59%ā†“

VEEV

209.29

-2.32%ā†“

A

98.9

-4.01%ā†“

CHE

569.14

-0.87%ā†“

HQY

76.28

-4.98%ā†“

MDT

81.74

-1.59%ā†“

VEEV

209.29

-2.32%ā†“

A

98.9

-4.01%ā†“

CHE

569.14

-0.87%ā†“

HQY

76.28

-4.98%ā†“

MDT

81.74

-1.59%ā†“

VEEV

209.29

-2.32%ā†“

A

98.9

-4.01%ā†“

CHE

569.14

-0.87%ā†“

HQY

76.28

-4.98%ā†“

MDT

81.74

-1.59%ā†“

VEEV

209.29

-2.32%ā†“

A

98.9

-4.01%ā†“

CHE

569.14

-0.87%ā†“

HQY

76.28

-4.98%ā†“

MDT

81.74

-1.59%ā†“

VEEV

209.29

-2.32%ā†“

A

98.9

-4.01%ā†“

CHE

569.14

-0.87%ā†“

HQY

76.28

-4.98%ā†“

Search

ADMA Biologics Inc

Chiusa

SettoreSettore sanitario

17.79 -3.37

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

17.56

Massimo

19.42

Metriche Chiave

By Trading Economics

Entrata

76M

112M

Vendite

-2.3M

118M

P/E

Media del settore

22.716

61.151

EPS

0.136

Margine di Profitto

95.191

Dipendenti

685

EBITDA

-2.7M

40M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+39.98% upside

Dividendi

By Dow Jones

Utili prossimi

8 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

554M

4.4B

Apertura precedente

21.16

Chiusura precedente

17.79

Notizie sul Sentiment di mercato

By Acuity

34%

66%

97 / 385 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

ADMA Biologics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 apr 2025, 22:42 UTC

I principali Market Mover

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 apr 2025, 22:35 UTC

Utili
I principali Market Mover

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 apr 2025, 21:30 UTC

Utili

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 apr 2025, 21:21 UTC

Utili

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 apr 2025, 00:00 UTC

Notizie principali

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 apr 2025, 23:45 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

8 apr 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 apr 2025, 23:43 UTC

Discorsi di Mercato

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 apr 2025, 23:43 UTC

Acquisizioni, Fusioni, Takeovers

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 apr 2025, 23:42 UTC

Discorsi di Mercato

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 apr 2025, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 apr 2025, 23:41 UTC

Acquisizioni, Fusioni, Takeovers

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 apr 2025, 23:40 UTC

Acquisizioni, Fusioni, Takeovers

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 apr 2025, 23:39 UTC

Acquisizioni, Fusioni, Takeovers

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 apr 2025, 23:21 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 apr 2025, 23:21 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 apr 2025, 21:26 UTC

Notizie principali

When Coffee Mate Made a 'White Lotus' PiƱa Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 apr 2025, 21:26 UTC

Utili

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 apr 2025, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 apr 2025, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 apr 2025, 21:06 UTC

Notizie principali

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 apr 2025, 20:50 UTC

Notizie principali

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 apr 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

8 apr 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

8 apr 2025, 20:49 UTC

Notizie principali

Vanguard Cuts Forecast for U.S. Economy. Tariffs Have Us 'Dancing With Recession.' -- Barrons.com

8 apr 2025, 20:40 UTC

Utili

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

Confronto tra pari

Modifica del prezzo

ADMA Biologics Inc Previsione

Obiettivo di Prezzo

By TipRanks

39.98% in crescita

Previsioni per 12 mesi

Media 25 USD  39.98%

Alto 25 USD

Basso 25 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ADMA Biologics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

2

Acquista

0

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

17.65 / 20.22Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

97 / 385 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

VolatilitĆ 

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.